Nootropics in New Zealand, cordyceps in South Korea, and the impact of China's daigou clampdown on companies like Swisse owner H&H all feature among our five most read stories on social media this month.
From novel lactoferrin encapsulation technology in Singapore and plant-derived omega-3 in India to clinical research on cordyceps, glucosamine and ginger, get the latest scientific stories in our news round-up.
Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
UK firm OptiBiotix is looking to increase its APAC presence, with Food Standards and Safety Authority of India (FSSAI) approval the latest development in its expansion plans withits weight management product, SlimBiome.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.